Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

January 31, 2002

Study Completion Date

January 31, 2002

Conditions
HIV Infections
Interventions
DRUG

Atazanavir

DRUG

Ritonavir

DRUG

Saquinavir

Trial Locations (38)

10011

St Vincents Hosp / Clinical Research Program, New York

12208

Albany Med College, Albany

29169

Julio Arroyo, West Columbia

30033

Infectious Disease Specialists of Atlanta, Decatur

33146

Community Research Initiative of South Florida, Coral Gables

33316

HIV Clinical Research, Fort Lauderdale

33614

Infectious Disease Research Institute, Tampa

35203

Sorra Research Ctr / Med Forum, Birmingham

37212

Vanderbilt Univ Med Ctr, Nashville

44106

Univ Hosps of Cleveland, Cleveland

70112

Louisiana State Univ Med Ctr / HIV Outpatient Clinic, New Orleans

75235

Univ of Texas Southwestern Med Ctr of Dallas, Dallas

77006

Houston Clinical Research Network / Div of Montrose Clinic, Houston

79905

Texas Tech Health Sciences Ctr, El Paso

90027

AIDS Healthcare Foundation, Los Angeles

91356

Avalar Medical Group, Tarzana

94609

Robert Scott MD, Oakland

95817

Univ of California - Davis Med Ctr / CARES, Sacramento

97210

The Research and Education Group, Portland

06510

Yale Univ School of Medicine / AIDS Program, New Haven

Unknown

Ottawa General Hospital, Ottawa

Toronto Hosp, Toronto

Montreal Chest Institute, Montreal

Hopital Pellegrin Tripode, Bordeaux

Hopital De L'Hotel Dieu, Nantes

Hopital De L'Archet 1, Nice

Srev Du Pr Gentilini, Paris

Hopital De Haut Leveque, Pessac

Hospital Gustave Dron, Tourcoing

Hopital Paul Brousse, Villejuif

Brennerstr 71, Hamburg

Georg-Str 46, Hanover

Praxisgemeinschaft, Munich

Reparto Malattie Infettive, Antella

Clinical Malattie Infettive, Milan

Ospedale Luigi Cacco Moroni, Milan

Clinical Malattie Infettive / Univ Modena, Modena

Ospedale degli Infermi, Rimini

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY